The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2022
DOI: 10.47102/annals-acadmedsg.2022193
|View full text |Cite
|
Sign up to set email alerts
|

Validation and comparison of the PECARN rule, Step-by-Step approach and Lab-score for predicting serious and invasive bacterial infections in young febrile infants

Abstract: Introduction: Differentiating infants with serious bacterial infections (SBIs) or invasive bacterial infections (IBIs) from those without remains a challenge. We sought to compare the diagnostic performances of single biomarkers (absolute neutrophil count [ANC], C-reactive protein [CRP] and procalcitonin [PCT]) and 4 diagnostic approaches comprising Lab-score, Step-by-Step approach (original and modified) and Pediatric Emergency Care Applied Research Network (PECARN) rule. Method: This is a prospective cohort… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…Existing published clinical prediction rules have variable performance in different populations. A prior external validation of the PECARN rule in our population reported a sensitivity of 88.9%, specificity of 28.9%, and a ROC of 0.59 (0.42–0.76) 19 . These studies focus on identifying a group at low risk of SBI 1 , while our aim is to derive a tool that predicts for SBI, thereby serving as an adjunct to help clinicians prioritize which febrile infant requires urgent further investigations and management.…”
Section: Discussionmentioning
confidence: 67%
“…Existing published clinical prediction rules have variable performance in different populations. A prior external validation of the PECARN rule in our population reported a sensitivity of 88.9%, specificity of 28.9%, and a ROC of 0.59 (0.42–0.76) 19 . These studies focus on identifying a group at low risk of SBI 1 , while our aim is to derive a tool that predicts for SBI, thereby serving as an adjunct to help clinicians prioritize which febrile infant requires urgent further investigations and management.…”
Section: Discussionmentioning
confidence: 67%
“…Our risk assessment tool that included practical, commonly collected clinical variables and was developed at sites in East and West Africa allows for greater generalisability than previous risk assessment tools for post-discharge mortality developed in single countries 10 11. The optimism corrected AUC of our tool aligns with prior risk assessment tools for post-discharge mortality among young children and would be considered acceptable for clinical use and aligns with test characteristics of other risk assessment tools that have been incorporated into clinical practice 57–61. However, because risk assessment tools perform best in their derivation set,15 this tool must be externally validated prior to clinical use.…”
Section: Discussionmentioning
confidence: 91%
“…10 11 The optimism corrected AUC of our tool aligns with prior risk assessment tools for post-discharge mortality among young children and would be considered acceptable for clinical use and aligns with test characteristics of other risk assessment tools that have been incorporated into clinical practice. [57][58][59][60][61] However, because risk assessment tools perform best in their derivation set, 15 this tool must be externally validated prior to clinical use. Although there were some differences in demographics of neonates discharged from the two included sites, our risk assessment tool may be more generalisable than prior tools as this is the first to overcome the inherent limitation of single-centre studies on post-discharge mortality.…”
Section: Discussionmentioning
confidence: 99%
“…The international literature shows various diagnostic protocols to distinguish low-risk situations from the high possibility of severe bacterial infection. However, none of them were demonstrated to be superior to the others [13,14]. The most important risk factors for severe bacterial infection are an age < 3 months of life, comorbidities, and immunodeficiencies [15].…”
Section: Of 14mentioning
confidence: 99%